PMID: 8583625Mar 1, 1996Paper

Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose

The Journal of Urology
P J EffertG Jakse

Abstract

We evaluated positron emission tomograph (PET) with 18fluorine (18F)-labeled deoxyglucose for metabolic grading of untreated primary prostate cancer, and differentiation of benign and malignant prostatic disease. A total of 48 patients with untreated prostate cancer of different stages and 16 with histologically confirmed benign prostatic hyperplasia (BPH) underwent static PET after intravenous injection of 150 to 300 MBq. 18F-deoxyglucose. 18F-deoxyglucose accumulation was quantitated by calculating differential uptake ratios and prostate-to-skeletal muscle ratios. Low 18F-deoxyglucose uptake was noted in the majority of primary tumors (81%). 18F-deoxyglucose accumulation did not correlate with increasing tumor grade or stage. There was a significant overlap in uptake values in BPH and malignant prostatic disease. A trend towards statistical significance was noted with lower prostate-to-skeletal muscle ratios in patients with BPH (p < 0.07). Increased 18F-deoxyglucose accumulation was detected in some patients with BPH and malignant prostatic disease, as well as in those with lymph node and bone metastases of prostate cancer. 18F-deoxyglucose PET does not allow for metabolic labeling in the majority of untreated primary prosta...Continue Reading

References

Jan 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·O M JensenH Renard
Jan 1, 1989·Journal of Neurosurgery·A WatanabeK Washiyama
Feb 1, 1984·Urology·R E DonohueR R Pfister
Jan 1, 1982·IEEE Transactions on Medical Imaging·L A Shepp, Y Vardi

❮ Previous
Next ❯

Citations

Jun 22, 2006·Der Urologe. Ausg. A·S N ReskeG Glatting
Sep 29, 2006·Der Urologe. Ausg. A·S N ReskeG Glatting
Aug 1, 2007·Der Urologe. Ausg. A·M SeitzC Stief
Oct 13, 2007·Der Urologe. Ausg. A·S N Reske
Feb 18, 2003·European Journal of Nuclear Medicine and Molecular Imaging·E FrickeA R Boerner
Aug 26, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Bernhard ScherStefan Dresel
Sep 24, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Michael McCarthyLaurence Morandeau
Sep 30, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Nobuyuki OyamaOsamu Yokoyama
Dec 1, 2009·Amino Acids·Hao HongWeibo Cai
Mar 28, 2009·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Mohsen BeheshtiWerner Langsteger
Jul 10, 2009·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Mohsen BeheshtiWerner Langsteger
Oct 12, 2010·Annals of Nuclear Medicine·Ryogo MinamimotoTomio Inoue
Nov 10, 2011·Annals of Nuclear Medicine·Masato ShiibaShin-ichiro Kumita
Jul 18, 2002·European Urology·I J de JongH J A Mensink
Jun 20, 1998·Seminars in Radiation Oncology·D H SilvermanM E Phelps
May 13, 2009·Nature Reviews. Urology·Hossein Jadvar
Oct 14, 2009·Molecular BioSystems·Raphael AlfordHisataka Kobayashi
Apr 12, 2001·BJU International·B A Wilkinson, F C Hamdy
Feb 3, 2006·The New England Journal of Medicine·Malik E Juweid, Bruce D Cheson
Mar 18, 2000·Japanese Journal of Clinical Oncology·N OyamaK Okada
Dec 14, 2007·Clinical Nuclear Medicine·José L CavalcantiHomer A Macapinlac
Jul 16, 2010·Clinical Nuclear Medicine·Shrikant Solav, Dhanpathi Halnaik
Sep 13, 2005·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·S F Hain
Jan 1, 2009·Advances in Urology·A H HouA B Barqawi
May 4, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael J MorrisHoward I Scher
Jun 21, 2008·World Journal of Surgical Oncology·Yiyan Liu
Sep 17, 2008·Radiation Oncology·Nidhi SharmaRoger Macklis
Sep 21, 2006·AJR. American Journal of Roentgenology·John F BruzziReginald F Munden
May 22, 2009·AJR. American Journal of Roentgenology·Baris TurkbeyPeter L Choyke
May 17, 2011·Future Oncology·Adel AbdellaouiSimon Freeman
Mar 9, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Mohammed HaseebuddinTom R Miller
Mar 30, 2007·Radiology·Hedvig HricakPeter T Scardino

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.